Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anammox upflow hybrid reactor: Nitrogen removal performance and potential for phosphorus recovery. | Chemosphere | 2023 | 36529167 | PubTator, text mining | PubMed |
| PGRMC1: An enigmatic heme-binding protein. | Pharmacol Ther | 2023 | 36463977 | PubTator, text mining | PubMed |
| Synergistic Cr(VI) reduction and adsorption of Cu(II), Co(II) and Ni(II) by zerovalent iron-loaded hydroxyapatite. | Chemosphere | 2023 | 36460147 | PubTator, text mining | PubMed |
| Regulating the Mechanical and Optical Properties of Polymer-based Nanocomposites by Sub-Nanowires. | Angew Chem Int Ed Engl | 2023 | 36394191 | PubTator, text mining | PubMed |
| Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy. | Pharm Res | 2023 | 36380167 | PubTator, text mining | PubMed |
| In situ synthesis of magnesium-doped hydroxyapatite aerogel for highly efficient U(VI) separation with ultra high adsorption capacity and excellent recyclability. | Chemosphere | 2023 | 36372341 | PubTator, text mining | PubMed |
| The durability of resin-dentine bonds are enhanced by epigallocatechin-3-gallate-encapsulated nanohydroxyapatite/mesoporous silica. | FEBS Open Bio | 2023 | 36350226 | PubTator, text mining | PubMed |
| Integration of ER protein quality control mechanisms defines β cell function and ER architecture. | J Clin Invest | 2023 | 36346671 | PubTator, text mining | PubMed |
| Multifunctional interfaces for multiple uses: Tin(II)-hydroxyapatite for reductive adsorption of Cr(VI) and its upcycling into catalyst for air protection reactions. | J Colloid Interface Sci | 2023 | 36334484 | PubTator, text mining | PubMed |
| A fijiviral nonstructural protein triggers cell death in plant and bacterial cells via its transmembrane domain. | Mol Plant Pathol | 2023 | 36305370 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| NSUN2-mediated mRNA m5C Modification Regulates the Progression of Hepatocellular Carcinoma. | Genomics Proteomics Bioinformatics | 2023 | 36183976 | PubTator, text mining | PubMed |
| Correlative Chemical Imaging Identifies Amyloid Peptide Signatures of Neuritic Plaques and Dystrophy in Human Sporadic Alzheimer's Disease. | Brain Connect | 2023 | 36074939 | PubTator, text mining | PubMed |
| A comprehensive review on recent advances in preparation, physicochemical characterization, and bioengineering applications of biopolymers. | Polym Bull (Berl) | 2023 | 36043186 | PubTator, text mining | PubMed |
| Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies. | Neural Regen Res | 2023 | 35799514 | PubTator, text mining | PubMed |
| 3D printing of bio-instructive materials: Toward directing the cell. | Bioact Mater | 2023 | 35574057 | PubTator, text mining | PubMed |
| Natural, synthetic and commercially-available biopolymers used to regenerate tendons and ligaments. | Bioact Mater | 2023 | 35510172 | PubTator, text mining | PubMed |
| Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs). | IUBMB Life | 2023 | 35499745 | PubTator, text mining | PubMed |
| Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. | Cell Biol Toxicol | 2023 | 34973136 | PubTator, text mining | PubMed |
| Oriented Crystallization of Hydroxyapatite in Self-Assembled Peptide Fibrils as a Bonelike Material. | ACS Biomater Sci Eng | 2023 | 34855358 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=16